| | | Single nucleotide variant (5 prime UTR variant +1 more) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | not specified | |
| | | Single nucleotide variant (missense variant +1 more) | Xeroderma pigmentosum, group G +4 more | GConflicting classifications of pathogenicity |
| | BIVM-ERCC5, ERCC5 (R71H +1 more) | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group G | |
| | BIVM-ERCC5, ERCC5 (T121I +1 more) | Single nucleotide variant (missense variant) | not specified | |
| | ERCC5, BIVM-ERCC5 (V145I +1 more) | Single nucleotide variant (missense variant) | not provided +1 more | |
| | ERCC5, BIVM-ERCC5 (P198T +1 more) | Single nucleotide variant (missense variant) | not specified +2 more | GConflicting classifications of pathogenicity |
| | BIVM-ERCC5, ERCC5 (R214C +1 more) | Single nucleotide variant (missense variant) | Cerebrooculofacioskeletal syndrome 3 +2 more | |
| | BIVM-ERCC5, ERCC5 (R214H +1 more) | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group G +2 more | |
| | BIVM-ERCC5, ERCC5 (M254V +1 more) | Single nucleotide variant (missense variant) | not specified +2 more | |
| | BIVM-ERCC5, ERCC5 (Q256R +1 more) | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group G +1 more | |
| | ERCC5, BIVM-ERCC5 (R263Q +1 more) | Single nucleotide variant (missense variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | BIVM-ERCC5, ERCC5 (S283F +1 more) | Single nucleotide variant (missense variant) | not specified | |
| | ERCC5, BIVM-ERCC5 (I292M +1 more) | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group G +1 more | |
| | BIVM-ERCC5, ERCC5 (A376V +1 more) | Single nucleotide variant (missense variant) | not provided +1 more | |
| | BIVM-ERCC5, ERCC5 (R420H +1 more) | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group G +2 more | GConflicting classifications of pathogenicity |
| | ERCC5, BIVM-ERCC5 (A447V +1 more) | Single nucleotide variant (missense variant) | not specified | |
| | ERCC5, BIVM-ERCC5 (G519E +1 more) | Single nucleotide variant (missense variant) | not specified | |
| | BIVM-ERCC5, ERCC5 (P524L +1 more) | Single nucleotide variant (missense variant) | not specified +3 more | |
| | BIVM-ERCC5, ERCC5 (C529S +1 more) | Single nucleotide variant (missense variant) | not specified +2 more | |
| | ERCC5, BIVM-ERCC5 (P571S +1 more) | Single nucleotide variant (missense variant) | not specified +1 more | GConflicting classifications of pathogenicity |
| | BIVM-ERCC5, ERCC5 (P580S +1 more) | Single nucleotide variant (missense variant) | not specified | |
| | BIVM-ERCC5, ERCC5 (V597L +1 more) | Single nucleotide variant (missense variant) | not provided +3 more | GConflicting classifications of pathogenicity |
| | BIVM-ERCC5, ERCC5 (E601G +1 more) | Single nucleotide variant (missense variant) | not provided | |
| | BIVM-ERCC5, ERCC5 (A627E +1 more) | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group G +1 more | |
| | BIVM-ERCC5, ERCC5 +1 more (G691R +1 more) | Single nucleotide variant (missense variant) | not provided | |
| | ERCC5, LOC126861834 +1 more (A761T +1 more) | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +3 more | |
| | BIVM-ERCC5, ERCC5 +1 more (H820Y +1 more) | Single nucleotide variant (missense variant) | not specified | |
| | BIVM-ERCC5, ERCC5 (R848W +1 more) | Single nucleotide variant (missense variant) | not specified | |
| | BIVM-ERCC5, ERCC5 (N879S +1 more) | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group G +1 more | |
| | BIVM-ERCC5, ERCC5 (R959S +1 more) | Single nucleotide variant (missense variant) | not provided | |
| | BIVM-ERCC5, ERCC5 (R964W +1 more) | Single nucleotide variant (missense variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | BIVM-ERCC5, ERCC5 (L999V +1 more) | Single nucleotide variant (missense variant) | Ovarian cancer +3 more | GConflicting classifications of pathogenicity |
| | BIVM-ERCC5, ERCC5 (R1009H +1 more) | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome | |
| | ERCC5, BIVM-ERCC5 (Q1013R +1 more) | Single nucleotide variant (missense variant) | Cerebrooculofacioskeletal syndrome 3 +1 more | GConflicting classifications of pathogenicity |
| | BIVM-ERCC5, ERCC5 (A1036T +1 more) | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group G +3 more | GConflicting classifications of pathogenicity |
| | ERCC5, BIVM-ERCC5 (G1053R +1 more) | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group G +1 more | |
| | ERCC5, BIVM-ERCC5 (G1080R +1 more) | Single nucleotide variant (missense variant) | not provided | |
| | ERCC5, BIVM-ERCC5 (R1080Q +2 more) | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group G +3 more | |
| | BIVM-ERCC5, ERCC5 (D1104H +1 more) | Single nucleotide variant (missense variant) | Cerebrooculofacioskeletal syndrome 3 +3 more | |
| | BIVM-ERCC5, ERCC5 (A1119V +1 more) | Single nucleotide variant (missense variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | BIVM-ERCC5, ERCC5 (A1143T +1 more) | Single nucleotide variant (missense variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | BIVM-ERCC5, ERCC5 (D1150G +1 more) | Single nucleotide variant (missense variant) | not specified | |